Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835796 · ClinicalTrials.gov registry record · Phase 1
Finasteride 5 mg Tablets, Non-fasting
A Phase 1 study, sponsored by Teva Pharmaceuticals USA.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00835796: Completed Phase 1 study, sponsored by Teva Pharmaceuticals USA.
NCT00835796 is a Phase 1 study that has completed, run by Teva Pharmaceuticals USA. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00835796, a Phase 1 study, has completed, sponsored by Teva Pharmaceuticals USA.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.
Interventions
- DRUG Finasteride 5 mg tablets
- DRUG PROSCAR® 5mg tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-06 |
| Est. Completion | 2002-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835796
The ClinicalTrials.gov registry entry for NCT00835796 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Pharmaceuticals USA, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Finasteride 5 mg tablets is the first listed.
NCT00835796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00835796 about?
NCT00835796 is a clinical study titled "Finasteride 5 mg Tablets, Non-fasting". The objective of this study is to compare the relative bioavailability of finasteride 5 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of PROSCAR® 5 mg tablets (Merck) in healthy, adult, non-smoking, male subjects under non-fasting conditions.
What is the current status of trial NCT00835796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2002-06. Estimated completion is 2002-07.
What interventions are being tested in trial NCT00835796?
The interventions under investigation include: Finasteride 5 mg tablets (DRUG), PROSCAR® 5mg tablets (DRUG).
Who is sponsoring clinical trial NCT00835796?
This trial is sponsored by Teva Pharmaceuticals USA, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.